GlycoMimetics (NASDAQ:GLYC) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Cantor Fitzgerald started coverage on shares of GlycoMimetics in a report on Friday, March 21st. They issued an “overweight” rating on the stock. One research […]
